DOI: 10.1055/s-00000077

Seminars in Thrombosis and Hemostasis

Issue 01 · Volume 11 · January 1985 DOI: 10.1055/s-002-7851

1
Fareed, Jawed: Heparin, Its Fractions, Fragments and Derivatives Some Newer Perspectives
1
Erratum
10
Coyne, Erwin: From Heparin to Heparin Fractions and Derivatives
13
Hirsh, Jack; Ofosu, Fred; Buchanan, Michael: Rationale Behind the Development of Low Molecular Weight Heparin Derivatives
17
Walenga, Jeanine M.; Fareed, Jawed; Hoppensteadt, Debra A.: In Vitro Coagulant and Amidolytic Methods for Evaluating the Activity of Heparin and a Low Molecular Weight Derivative (PK 10169)
26
Barlow, Grant H.: The Determination of Molecular Weight Distributions on Heparin Samples
29
Losito, Ray; Losito, Carine: Molecular Weight of Heparin Versus Biologic Activity Some Additional Considerations
34
Mardiguian, Jean; Trillou, Michele: An Investigation of the Functional Role of the Carboxylic Groups of Heparin Affinity for Antithrombin III and Anti-Xa Activity of Selectively Carboxyl Esterified Heparin
37
Lasker, Sigmund E.: Low Molecular Weight Heparin-Like Preparations with Oral Activity
40
Walz, Daniel A.; Hung, Guo-Long: In Vivo Studies on the Binding of Heparin and Its Fractions with Platelet Factor 4
48
Engelberg, Hyman: Heparin, Heparin Fractions, and the Atherosclerotic Process
56
Fareed, Jawed; Walenga, Jeanine M.; Williamson, Karen; Emanuele, R. Martin; Kumar, Arvind; Hoppensteadt, Debra A.: Studies on the Antithrombotic Effects and Pharmacokinetics of Heparin Fractions and Fragments
75
Murano, Genesio; Bick, Rodger L.: Abstracts of Current Literature